NASDAQ: TRIB - Trinity Biotech plc

Yield per half year: -68.16%
Dividend yield: 0.00%
Sector: Healthcare

Trinity Biotech plc

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
33.5 61.47 -45.51% 5.11 +555.63%
P/S 0.0642 33.58 -99.81%
P/BV -0.1524 4.79 -103.18%
P/FCF -1.29 61 -102.11%
Ev/Ebitda -5 -17.26 -71.05%
Ev/S 1.19 22.5 -94.73%
Ev/FCF -3.08 69 -104.46%
E/P -0.8517 0.0178 -4891.92%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-23.73 4.97 -577.19% -14.28 +66.1%
ROE 100.29 9.61 943.41%
ROA -40.41 0.3443 -11838.39%
ROIC -1.57 7.63 -120.56%
ROS -42.26 -25.17 67.9%
ROCE 63.72 15.19 319.59%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-4.19 -3.67 14.37% -1.69 +148.62%
Nеt Debt/Ebitda -4.73 -4.06 16.49%
Debt/Ratio 0.9515 0.199 378.14%
Debt/Equity 1.21 1.54 -21.52%
Debt/Net Income -2.35 10.34 -122.77%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5399 -100% 1.19 -100%
Number of years of dividend growth 0 0.7368 -100%
DSI 0.8333 0.2256 269.44%
Average dividend growth 16.86 0.9598 1656.16%
Average percentage for 5 years 1.19 0.4928 141.49%
Average percentage for payments 31.5 43.56 -27.69%
Difference from average difference in sector -0.5399

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-36.85 76.2 -148.36%
Growth impulse Ebitda in 5 years -4 44.75 -108.94%
Growth impulse Net Income in 5 years -17.18 -15.36 11.85%
Growth impulse FCF in 5 years 137.68 -108.72 -226.64%
Growth impulse EPS in 5 years 124.11 -142.05 -187.37%
IP Score
5.23/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription